OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Alternative platelet activation pathways and their role in neurodegenerative diseases
Paula Ferrer‐Raventós, Katrin Beyer
Neurobiology of Disease (2021) Vol. 159, pp. 105512-105512
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

Energy metabolism in health and diseases
Hui Liu, Shuo Wang, Jianhua Wang, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 8

Alterations in the Processing of Platelet APP (Amyloid Beta Precursor Protein) in Alzheimer Disease: The Possible Nexus
Hayder M. Al‐kuraishy, Ghassan M. Sulaiman, Hamdoon A. Mohammed, et al.
Neuropsychopharmacology Reports (2025) Vol. 45, Iss. 1
Open Access | Times Cited: 3

The multifaceted role of platelets in mediating brain function
Thierry Burnouf, Tara L. Walker
Blood (2022) Vol. 140, Iss. 8, pp. 815-827
Open Access | Times Cited: 34

Antiplatelet drugs: Potential therapeutic options for the management of neurodegenerative diseases
Samir Kumar Beura, Rishika Dhapola, Abhishek Panigrahi, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 1835-1877
Closed Access | Times Cited: 20

Neutrophil Extracellular Traps in Cerebral Ischemia/Reperfusion Injury: Friend and Foe
Haoyue Luo, Hanjing Guo, Yue Zhou, et al.
Current Neuropharmacology (2023) Vol. 21, Iss. 10, pp. 2079-2096
Open Access | Times Cited: 17

Role of platelet in Parkinson’s disease: Insights into pathophysiology & theranostic solutions
Samir Kumar Beura, Abhishek Panigrahi, Pooja Yadav, et al.
Ageing Research Reviews (2022) Vol. 80, pp. 101681-101681
Closed Access | Times Cited: 23

From blood vessels to brain cells: Connecting the circulatory system and Parkinson's disease
Oyedele J. Olaoye, Sophie Farrow, Denis M. Nyaga, et al.
Journal of Parkinson s Disease (2025)
Open Access

Targeting Platelet Activating Factor Signaling for Therapeutic Benefits in Neurodegenerative Disorders
Theodora Adamantidi, Andreas M. Grabrucker, Αλέξανδρος Τσούπρας
Frontiers in Bioscience-Landmark (2025) Vol. 30, Iss. 4
Open Access

Aβ1-42-containing platelet-derived extracellular vesicle is associated with cognitive decline in Parkinson’s disease
Ziyu Wang, Yuanchu Zheng, Huihui Cai, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 10

The platelet transcriptome and proteome in Alzheimer’s disease and aging: an exploratory cross-sectional study
Diana M Bessa de Sousa, Rodolphe Poupardin, Saul Villeda, et al.
Frontiers in Molecular Biosciences (2023) Vol. 10
Open Access | Times Cited: 8

Blood-based bioenergetics: a liquid biopsy of mitochondrial dysfunction in disease
Mia Wilkinson, Kimberly J. Dunham‐Snary
Trends in Endocrinology and Metabolism (2023) Vol. 34, Iss. 9, pp. 554-570
Open Access | Times Cited: 7

The Well-Forgotten Old: Platelet-Rich Plasma in Modern Anti-Aging Therapy
Anna V. Gorodilova, Chulpan B. Kharisova, Maria N. Osinnikova, et al.
Cells (2024) Vol. 13, Iss. 21, pp. 1755-1755
Open Access | Times Cited: 2

Platelet mitochondria, a potent immune mediator in neurological diseases
Yan Ma, Qian Jiang, Bingxin Yang, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 5

Morphometric and Nanomechanical Screening of Peripheral Blood Cells with Atomic Force Microscopy for Label-Free Assessment of Alzheimer’s Disease, Parkinson’s Disease, and Amyotrophic Lateral Sclerosis
Stefka G. Taneva, Svetla Todinova, Tonya Andreeva
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14296-14296
Open Access | Times Cited: 5

Brain-Region-Specific Differences in Protein Citrullination/Deimination in a Pre-Motor Parkinson’s Disease Rat Model
Audrey Mercer, Marco Sancandi, Amy MacLatchy, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11168-11168
Open Access | Times Cited: 1

Platelets’ Nanomechanics and Morphology in Neurodegenerative Pathologies
Velichka Strijkova, Svetla Todinova, Tonya Andreeva, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2239-2239
Open Access | Times Cited: 7

Biochemical Platelet Markers of Cognitive Impairments in Alzheimer’s Disease
А. Н. Кодинцев, Н. В. Изможерова, Popov Aa, et al.
Neurochemical Journal (2023) Vol. 17, Iss. 1, pp. 10-18
Closed Access | Times Cited: 3

Early platelet level reduction as a prognostic factor in intensive care unit patients with severe aspiration pneumonia
Lina Wang, Daikun He, Yiru Shao, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 2

Pathophysiological subtypes of mild cognitive impairment due to Alzheimer’s disease identified by CSF proteomics
Daniela Moutinho, Vera M. Mendes, Alessandro Caula, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access

Impact of 6-Hydroxydopamine on Agonist-Induced human platelet functional Parameters: An explanation for platelet impairment in Parkinson’s disease
Samir Kumar Beura, Pooja Yadav, Abhishek Panigrahi, et al.
Neuroscience (2024) Vol. 559, pp. 237-248
Closed Access

Page 1 - Next Page

Scroll to top